| Price Range 12mo avg: | $2M – $2.5M |
|---|---|
| $/sf 12mo avg: | $318.75 |
| CAP Rate 12mo avg: | 7.29% |
| NOI average: | $173,700 |
| Lease Terms: | 15yrs NNN |
| Building Size avg: | 7,500 SF |
| Lot Size avg: | 2.5+/- acres |
Fresenius is a global health care group with products and services for dialysis, the hospital and the medical care of patients at home.
The Fresenius Group consists of the following four business segments that are responsible for their own business operations worldwide: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed.
Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and the New York Stock Exchange (FMS)
Fresenius Medical Care is the world’s largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.7 million individuals worldwide. Through its network of 3,361 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatments for 286,312 patients around the globe. Fresenius Medical Care is also the world’s leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products.
| S&P Credit Rating: | BBB- |
|---|---|
| Moody’s Credit Rating: | Ba1 |
| Annual Revenue 2014: | $15.8B |
| Annual Revenue 2013: | $14.6B |
| Revenue Growth: | ↑ 8% from 2013 |
| Net Income | $1.05B |
| Units (Dec. 2014) | 3,361 |
| Average Units Volume: | $4.7M |
Yahoo! Finance: FMS News Latest Financial News for FMS
-
ETFs with exposure to Fresenius Medical Care AG & Co. KGaA : July 12, 2017
on July 12, 2017 at 6:32 pm
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Fresenius Medical Care AG & Co. KGaA Here are 5 ETFs with the largest exposure to FMS-US. Comparing the performance and risk of Fresenius Medical Care AG & Co. KGaA with the ETFs that have exposure to it gives us some ETF choices that could ... Read more (Read more...) […]
-
William McKinney, Fresenius Medical Care North America, Named Chair of Austin Kidney Walk
on July 12, 2017 at 3:51 pm
The National Kidney Foundation announces that William McKinney, President of Fresenius Medical Care North America’s Integrated Care Group, which includes Fresenius Health Partners and FreseniusRx, will serve as this year's Corporate Chairman for the Austin Kidney Walk to be held Sunday, Nov. […]
-
Fresenius Medical (FMS) Well Poised on Growth Strategy 2020
on July 12, 2017 at 1:41 pm
On Jul 11, we issued an updated research report on Bad Homburg, Germany-based Fresenius Medical Care (FMS), one of the largest integrated providers of products and services for individuals undergoing dialysis following chronic kidney failure. […]
-
Fresenius Medical Care Holdings, Inc. -- Moody's upgrades FMCH's long term issuer rating to Baa3, outlook stable
on July 7, 2017 at 10:02 am
Rating Action: Moody's upgrades FMCH's long term issuer rating to Baa3, outlook stable. Global Credit Research- 07 Jul 2017. Frankfurt am Main, July 07, 2017-- Moody's Investors Service, has today upgraded ... […]
-
Frenova Renal Research Announces Expansion of F1RST Up™ (Frenova Rapid STart Up) Alliance of Investigative Sites Designed to Speed Clinical Trial Initiation
on June 20, 2017 at 1:30 pm
Frenova Renal Research, the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research, today announced that its F1RST Up™ alliance of clinical research sites focusing on kidney disease has expanded to include 55 physician investigators representing 23 sites. […]
NYSE: FMS
